https://ir.acimmune.com/ 2025-11-04T08:06:37-05:00 daily 1.0 https://ir.acimmune.com/committee-details/audit-and-finance-committee 2025-06-19T12:20:40-04:00 0.5 https://ir.acimmune.com/committee-details/compensation-nomination-and-corporate-governance-committee 2025-06-19T12:14:42-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-ordinary-shareholders-meeting 2017-06-29T04:03:59-04:00 0.5 https://ir.acimmune.com/events/event-details/credit-suisse-healthcare-conference 2017-11-16T06:23:41-05:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-london-healthcare-conference 2019-04-06T06:19:07-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-key-opinion-leader-kol-luncheon 2019-07-12T23:08:22-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-credit-suisse-2018-global-healthcare-conference 2019-04-06T08:09:49-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-aat-adpdtm-conference 2019-04-06T09:09:34-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-leerink-partners-annual-global-healthcare-conference 2019-07-12T23:08:22-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-hc-wainwright-global-life-sciences-conference 2018-12-26T03:45:09-05:00 0.5 https://ir.acimmune.com/events/event-details/extraordinary-shareholders-meeting 2018-04-27T12:50:05-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-ordinary-shareholders-meeting-0 2018-07-06T07:53:07-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-key-opinion-leader-kol-luncheon-abeta-oligomers-and-concomitant 2019-07-12T23:08:22-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-jefferies-2018-london-healthcare-conference 2018-11-12T00:39:06-05:00 0.5 https://ir.acimmune.com/events/event-details/webcast-ac-immune-ceo-andrea-pfeifer-world-economic-forum 2019-01-22T09:49:00-05:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-hc-wainwright-global-life-sciences-conference-0 2019-04-10T10:23:10-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-ordinary-shareholders-meeting-1 2025-10-02T03:39:59-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-key-opinion-leader-kol-breakfast-treating-alzheimers-disease-people 2019-07-02T16:50:12-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-key-opinion-leader-event-untangling-tau-pathology-treat-alzheimers 2019-11-06T13:02:35-05:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-jefferies-2019-london-healthcare-conference 2019-11-14T09:40:34-05:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-ubs-virtual-global-healthcare-conference 2020-05-15T08:33:35-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-ordinary-shareholders-meeting-2 2025-10-02T03:40:45-04:00 0.5 https://ir.acimmune.com/events/event-details/svb-leerink-second-annual-cns-forum 2020-07-01T16:02:09-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-h-c-wainwright-22nd-annual-global-investment-conference 2020-09-11T09:26:53-04:00 0.5 https://ir.acimmune.com/events/event-details/extraordinary-shareholders-meeting-0 2021-02-23T13:22:58-05:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-jefferies-virtual-london-healthcare-conference 2020-11-12T08:13:29-05:00 0.5 https://ir.acimmune.com/events/event-details/global-be-brain-powerful-braintrust-dialogues-worldview 2021-01-25T11:26:14-05:00 0.5 https://ir.acimmune.com/events/event-details/world-economic-forum-davos-dialogues-tackling-todays-silent-global-pandemic 2021-01-25T11:25:49-05:00 0.5 https://ir.acimmune.com/events/event-details/svb-leerink-10th-annual-global-healthcare-conference 2021-02-17T08:45:54-05:00 0.5 https://ir.acimmune.com/events/event-details/extraordinary-shareholders-meeting-1 2021-05-20T12:21:07-04:00 0.5 https://ir.acimmune.com/events/event-details/adpdtm-2021-virtual-conference 2021-03-08T17:51:47-05:00 0.5 https://ir.acimmune.com/events/event-details/2021-global-down-syndrome-forum 2021-04-28T08:39:48-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immunes-morphomertm-small-molecule-technology-platform-and-pipeline 2021-03-31T08:15:26-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-ubs-global-healthcare-virtual-conference 2021-05-21T10:21:59-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-jefferies-virtual-healthcare-conference 2021-05-20T08:19:09-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-general-meeting-2021 2025-10-02T03:38:36-04:00 0.5 https://ir.acimmune.com/events/event-details/mental-health-resilience-after-covid 2021-06-24T05:15:57-04:00 0.5 https://ir.acimmune.com/events/event-details/aciu-conference-call 2021-07-27T08:01:40-04:00 0.5 https://ir.acimmune.com/events/event-details/citi-16th-annual-biopharma-virtual-conference 2021-09-02T08:28:44-04:00 0.5 https://ir.acimmune.com/events/event-details/morgan-stanley-19th-annual-global-healthcare-conference 2022-02-07T10:13:26-05:00 0.5 https://ir.acimmune.com/events/event-details/hc-wainwright-23rd-annual-global-investment-conference 2021-09-02T10:23:33-04:00 0.5 https://ir.acimmune.com/events/event-details/extraordinary-general-meeting-2021 2022-03-22T15:04:01-04:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-london-healthcare-conference-0 2021-11-12T09:21:22-05:00 0.5 https://ir.acimmune.com/events/event-details/hmw-inside-call-ac-immune-mit-dr-matthias-hallweger-und-prof-dr-andrea-pfeifer 2022-03-16T15:44:48-04:00 0.5 https://ir.acimmune.com/events/event-details/svb-leerink-11th-annual-global-healthcare-conference 2022-03-16T15:45:29-04:00 0.5 https://ir.acimmune.com/events/event-details/key-opinion-leader-webinar-alpha-synuclein-target-neurodegenerative-diseases 2022-03-30T09:13:35-04:00 0.5 https://ir.acimmune.com/events/event-details/b-riley-annual-neuro-ophthalmology-virtual-investor-conference 2022-04-27T07:07:43-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-general-meeting-2022 2023-05-24T16:25:26-04:00 0.5 https://ir.acimmune.com/events/event-details/2022-jefferies-healthcare-conference 2022-06-03T08:11:50-04:00 0.5 https://ir.acimmune.com/events/event-details/alzheimers-association-international-conference 2022-07-25T05:50:26-04:00 0.5 https://ir.acimmune.com/events/event-details/key-opinion-leader-kol-webinar-vaccinations-treat-and-prevent-alzheimers-and 2022-08-11T08:15:14-04:00 0.5 https://ir.acimmune.com/events/event-details/2022-jefferies-london-healthcare-conference 2022-11-08T08:59:04-05:00 0.5 https://ir.acimmune.com/events/event-details/svb-securities-global-biopharma-conference 2023-02-02T08:33:59-05:00 0.5 https://ir.acimmune.com/events/event-details/mig-inside-webinar-impfstoffe-gegen-alzheimer-parkinson-und-co 2023-02-16T05:26:14-05:00 0.5 https://ir.acimmune.com/events/event-details/key-opinion-leader-kol-webinar-early-diagnosis-and-prevention-alzheimers 2023-04-20T07:57:56-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-general-meeting-2023 2025-10-02T03:36:43-04:00 0.5 https://ir.acimmune.com/events/event-details/btig-virtual-biotechnology-conference-2023 2023-07-28T09:11:40-04:00 0.5 https://ir.acimmune.com/events/event-details/hc-wainwright-25th-annual-global-investment-conference 2023-09-05T10:03:26-04:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-2023-cns-neuro-summit 2023-10-05T11:06:42-04:00 0.5 https://ir.acimmune.com/events/event-details/kol-webinar-amyloid-plaque-pet-imaging-alzheimers-disease-surrogate-clinical 2023-11-02T08:14:29-04:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-2023-london-healthcare-conference 2023-11-07T08:43:52-05:00 0.5 https://ir.acimmune.com/events/event-details/adpdtm-2024-symposium 2024-03-11T09:53:45-04:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-sa-conference-call-webcast 2024-05-13T08:03:23-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-general-meeting-2024 2025-10-02T03:33:32-04:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-2024-global-healthcare-conference 2024-05-28T11:30:02-04:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-2024-london-healthcare-conference 2024-11-13T13:16:24-05:00 0.5 https://ir.acimmune.com/events/event-details/leerink-partners-2025-global-healthcare-conference 2025-03-04T07:54:50-05:00 0.5 https://ir.acimmune.com/events/event-details/barclays-27th-annual-global-healthcare-conference 2025-03-04T07:55:30-05:00 0.5 https://ir.acimmune.com/events/event-details/adpdtm-2025-symposium 2025-04-02T11:21:02-04:00 0.5 https://ir.acimmune.com/events/event-details/annual-general-meeting-2025 2025-05-19T04:25:03-04:00 0.5 https://ir.acimmune.com/events/event-details/jefferies-2025-london-healthcare-conference 2025-11-11T07:21:12-05:00 0.5 https://ir.acimmune.com/events/event-details/ac-immune-conference-call-december-2025 2025-12-11T09:38:26-05:00 0.5 https://ir.acimmune.com/events/event-details/adpd-2026-symposium 2026-03-20T08:41:09-04:00 0.5 https://ir.acimmune.com/investor-overview 2025-11-04T08:06:37-05:00 0.8 https://ir.acimmune.com/news 2022-03-11T08:57:58-05:00 0.8 https://ir.acimmune.com/events-and-presentation 2022-05-09T16:45:00-04:00 0.8 https://ir.acimmune.com/governance 2025-06-19T12:28:45-04:00 0.8 https://ir.acimmune.com/sec-filings 2022-02-24T08:21:42-05:00 0.8 https://ir.acimmune.com/annual-reports 2024-03-14T11:16:26-04:00 0.8 https://ir.acimmune.com/stock-information/analyst-coverage 2024-06-02T06:47:56-04:00 0.8 https://ir.acimmune.com/stock-information 2022-02-22T06:00:12-05:00 0.8 https://ir.acimmune.com/stock-information/historical-price-lookup 2021-11-03T03:48:17-04:00 0.8 https://ir.acimmune.com/stock-information/investment-calculator 2021-11-03T03:52:51-04:00 0.8 https://ir.acimmune.com/email-alerts 2021-09-16T07:27:31-04:00 0.8 https://ir.acimmune.com/events/agm 2025-05-19T04:27:34-04:00 0.8 https://ir.acimmune.com/document-request 2021-09-14T21:50:20-04:00 0.8 https://ir.acimmune.com/contact-ir 2022-02-24T08:38:54-05:00 0.8 https://ir.acimmune.com/events/egm 2021-11-09T11:50:36-05:00 0.8 https://ir.acimmune.com/stock-information/why-invest 2022-02-23T04:11:08-05:00 0.8 https://ir.acimmune.com/stock-information/key-figures 2025-11-04T07:43:07-05:00 0.8 https://ir.acimmune.com/in-the-news 2022-06-01T13:41:53-04:00 0.8 https://ir.acimmune.com/stock-information/faq 2022-02-23T04:19:47-05:00 0.8 https://ir.acimmune.com/privacy-notice 2021-11-15T10:56:58-05:00 0.8 https://ir.acimmune.com/stock-information/page-milestones 2025-09-04T09:15:05-04:00 0.8 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2016-results 2019-03-19T12:25:26-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-announces-results-annual-general-meeting 2019-03-19T10:32:59-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-appoints-experienced-life-science-professional-new 2019-03-19T10:30:19-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-partner-genentech-presents-important-data-alzheimers 2016-12-09T15:53:37-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-partner-genentech-start-second-phase-3-clinical-trial 2019-03-19T10:58:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2016-financial-results-and-rd-update 2019-03-19T11:01:26-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provides-twelve-updates-its-pipeline-international 2019-03-19T11:04:49-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/piramal-imaging-and-ac-immune-present-first-clinical-data-tau 2019-03-19T11:08:11-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-reports-first-quarter-2017-financial-results 2019-03-19T11:11:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-essex-bio-technology-announce-research 2019-03-19T11:15:00-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-results-annual-general-meeting 2019-03-19T11:17:44-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provides-seven-updates-its-pipeline-and-technology 2019-03-19T11:21:09-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2017-financial-results 2019-03-19T11:23:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-discovers-next-generation-antibodies-focused 2019-03-19T11:26:36-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-completes-recruitment-low-dose-cohort-worlds-first 2019-03-19T11:29:54-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-awarded-continuation-2015-grant-michael-j-fox 2019-03-19T11:33:29-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-two-investor-conferences-and-provide 2019-03-19T11:40:37-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-receive-milestone-payment-anti-tau-antibody-moving 2019-03-19T11:43:12-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-reports-third-quarter-2017-financial-results-and 2019-03-19T11:46:35-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-meeting-tau-therapeutic-and 2019-03-19T11:49:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-shares-insights-key-opinion-leader-meeting-tau 2019-03-19T11:51:47-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-participate-two-investor-conferences-and-provide 2019-03-19T12:34:52-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-prepares-first-human-study-promising-positron-emission 2019-03-19T12:34:37-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2017-financial-results-successful 2019-03-19T12:34:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-selection-tau-small-molecules-clinical-0 2019-03-19T12:34:05-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-results-extraordinary-shareholders-meeting-0 2019-03-19T12:33:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-quarter-2018-financial-results-and-0 2019-03-19T12:36:04-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-results-annual-general-meeting-0 2019-03-19T12:25:48-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/crenezumabs-second-phase-3-trial-cread-2-fully-recruited-updates 2019-03-19T12:25:23-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-offerings-and-issuance-10-million-common 2019-03-19T12:24:58-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-price-usd-1175-offerings-and-issuance-10 2019-03-19T12:24:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-closing-first-subscription-rights-offering 2019-03-19T12:24:14-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/new-phase-2-data-analysis-crenezumab-presented-global-alzheimers 2019-03-19T12:23:55-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-successful-closing-second-subscription 2019-03-19T12:23:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2018-financial-results-and 2019-03-19T12:09:43-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-important-clinical-milestones-aci-24-vaccine 2019-03-19T12:09:25-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-dr-andreas-muhs-chief-scientific-officer 2019-03-19T12:09:02-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-selected-present-progress-its-tau-morphomer-program 2019-03-19T12:08:25-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-new-data-supporting-crenezumab-potential-alzheimers 2019-03-19T12:07:54-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-partner-life-molecular-imaging-presents-new-clinical 2019-03-19T12:07:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-meeting-abeta-oligomers 2019-03-19T11:58:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-2018-society-neurosciences-meeting 2019-03-19T11:57:59-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-shares-insights-key-opinion-leader-meeting-abeta 2019-03-19T11:57:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-2018-london-healthcare-conference 2019-03-19T11:57:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2018-financial-results-and 2019-03-19T11:56:50-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-awarded-third-follow-grant-michael-j-fox-foundation 2019-03-19T11:56:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-lilly-announce-license-and-collaboration-agreement 2019-03-19T11:18:45-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-wuxi-biologics-establish-exclusive-strategic 2019-03-19T11:18:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-appointment-dr-marie-kosco-vilbois-chief 2019-03-19T10:57:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-discontinuation-phase-iii-cread-1-and-2 2019-03-19T10:47:00-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-makes-two-appointments-executive-committee-accelerate 2019-03-19T10:40:19-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-anti-tau-monoclonal-antibody-entering-second 2019-03-19T10:25:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-report-progress-early-stage-pipeline-adpdtm-congress 2019-04-22T15:06:52-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-commences-proposed-initial-public-offering-common 2019-03-11T12:56:39-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-raises-chf-21-million-private-financing-round 2019-03-19T09:31:46-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/genentech-and-ac-immune-exclusive-license-agreement 2019-03-19T09:32:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/technology-pioneer-2009-ac-immune-highlights-significant 2019-03-19T09:32:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-shapes-its-future-world-economic-forum-technology 2019-03-19T09:32:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-bayer-schering-pharma-collaborate-brain-imaging 2019-03-19T09:33:53-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/prof-andrea-pfeifer-ceo-ac-immune-awarded-swiss-life-sciencehigh 2019-03-19T09:34:16-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-boosts-its-preclinical-alzheimers-pipeline 2019-03-19T09:34:56-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/prof-andrea-pfeifer-represents-switzerland-election-ernst-young 2019-03-19T09:35:24-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-recieves-significant-milestone-payment-genentech 2019-03-19T09:35:57-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/development-new-medicines-memory-impairment 2019-03-19T09:36:58-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-therapy-chosen-groundbreaking-alzheimers-disease-trial 2019-03-19T09:37:29-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-genentech-enter-second-antibody-collaboration 2019-03-19T09:52:38-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-named-one-fierce-15-leading-biotech-companies-2012 2019-03-19T09:53:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/fiercebiotech-recognition-prof-pfeifers-personal-qualities 2019-03-18T13:19:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-discontinue-development-aci-91-small-molecule 2019-03-19T10:05:39-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/alzheimers-prevention-initiative-api-trial-marks-milestone 2019-03-19T10:06:06-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-raises-chf-20-million-and-initiates-worlds-first-anti 2019-03-19T10:06:32-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-piramal-imaging-announce-out-licensing-agreement 2019-03-19T10:07:09-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/crenezumab-phase-ii-cognition-data-alzheimers-disease-presented 2019-03-19T10:08:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-enters-worldwide-license-and-collaboration-agreement 2019-03-19T10:09:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-awarded-grant-michael-j-fox-foundation-parkinsons 2019-03-19T10:25:41-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-milestone-anti-tau-antibody-collaboration 2019-03-19T10:26:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-milestone-payment-crenezumab-moving-phase-iii 2019-03-19T10:29:15-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-signs-collaboration-agreement-nestle-institute-health 2019-03-19T10:29:47-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/worlds-first-clinical-trial-anti-abeta-vaccine-targeting 2019-03-18T16:50:32-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-publication-ground-breaking-scientific 2019-03-18T16:54:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-research-and-development-collaboration 2019-03-18T16:59:03-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-raises-usd-435-million-chf-427-million-financing-round 2019-03-19T10:53:01-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receive-milestone-payment-anti-tau-antibody-moving 2019-03-18T17:08:09-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-announces-pricing-upsized-initial-public-offering 2019-04-06T05:00:44-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/switzerlands-ac-immune-opens-trading-nasdaq 2019-03-18T17:18:41-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/memoriam-dr-andreas-muhs-cso-scientific-leader-and-friend-has 2019-03-19T12:49:03-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/new-clinical-data-ac-immunes-novel-next-generation-tau-pet 2019-04-06T03:35:55-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-presents-new-data-alpha-synuclein-pet-tracer-adpdtm 2019-04-06T03:38:40-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-hc-wainwright-global-life-sciences-conference 2019-04-06T03:39:53-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2018-financial-results-and-provides 2019-04-06T03:32:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2018-financial-results-and-0 2019-03-21T07:00:15-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/new-clinical-data-ac-immunes-novel-next-generation-tau-pet-0 2019-03-27T07:00:28-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-presents-new-data-alpha-synuclein-pet-tracer-adpdtm-0 2019-03-29T02:00:55-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-hc-wainwright-global-life-sciences-0 2019-04-01T07:00:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-q1-2019-financial-results-and-business-update 2019-06-06T20:02:36-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-q1-2019-financial-results-and-business-0 2019-06-06T20:11:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-initiation-phase-2-substudy-increase 2019-06-20T07:01:32-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-meeting-treating-alzheimers 2019-06-27T07:01:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-election-new-chairman-board-annual-general 2019-06-28T08:37:32-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-hosts-kol-event-and-reports-initial-interim-clinical 2019-07-11T08:01:54-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-initiates-phase-1-study-aci-3024-small-molecule-tau 2019-07-17T07:00:55-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-initiates-ph1b2a-study-anti-phospho-tau-vaccine 2019-08-01T07:02:18-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-research-collaboration-university 2019-08-12T07:00:40-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-q2-2019-financial-results-business-and 2019-08-14T07:00:49-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-awarded-michael-j-fox-foundation-grant-accelerate 2019-09-04T07:01:03-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-milestone-payment-connection-initiation-phase 2019-09-17T02:00:36-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-first-milestone-payment-lilly-small-molecule 2019-09-20T07:00:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-event-untangling-tau-pathology 2019-10-24T07:01:09-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-hosts-key-opinion-leader-event-untangling-tau 2019-11-06T16:07:41-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-q3-2019-financial-results-and-business-update 2019-11-13T07:00:57-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-2019-london-healthcare-conference 2019-11-15T11:57:34-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-new-data-demonstrating-depth-its 2021-03-23T06:43:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/internationally-renowned-neurologist-dr-juan-fortea-joins-ac 2020-03-20T07:19:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-second-milestone-and-new-milestone-increase 2020-03-23T07:01:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2019-financial-results-and-provides 2020-03-30T07:01:00-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-presents-latest-preclinical-data-novel-drug-targets 2020-04-02T07:01:20-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-q1-2020-financial-results-and-provides 2020-05-04T09:34:01-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-ceo-showcase-novel-target-programs-ubs-global 2020-05-15T07:01:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-results-annual-general-meeting-1 2020-06-26T07:21:25-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/tau-pet-tracer-pi-2620-could-set-new-standards-improved 2020-07-07T10:29:15-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-advances-phospho-tau-alzheimers-vaccine-phase-1b2a 2020-07-16T07:20:28-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-advances-two-companys-world-leading-programs 2020-07-23T07:27:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-demonstrates-enhanced-performance-first-class 2020-07-28T07:01:15-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-wins-prestigious-award-develop-game-changing 2020-07-30T07:55:30-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-initiates-ind-enabling-studies-first-class-antibody 2020-08-03T07:00:49-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-q2-2020-financial-results-and-provides 2020-08-05T07:41:36-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-showcase-anti-tau-portfolio-hc-wainwright-22nd-annual 2020-09-11T09:28:58-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-top-line-results-tauriel-phase-2-trial 2020-09-23T07:02:12-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/competitive-eu-grant-supports-collaboration-accelerate 2020-10-09T08:59:18-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-wuxi-biologics-strengthen-strategic-partnership 2020-11-09T04:11:02-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provide-strategy-and-pipeline-update-during-jefferies 2020-11-12T07:01:29-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-q3-2020-financial-results-and-provides 2020-11-13T07:12:35-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/neurologist-and-psychiatrist-prof-johannes-rolf-streffer-md 2020-11-18T08:15:15-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/immunotherapy-pioneer-prof-carl-h-june-joins-ac-immunes-board 2020-11-20T09:03:39-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-competitive-target-als-foundation-grant 2020-12-15T08:13:32-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-progress-therapeutic-programs-targeting-nlrp3 2021-01-29T07:15:26-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-initiates-clinical-study-first-class-diagnostic 2021-02-08T07:04:13-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-alzheimers-vaccine-generates-potent-anti-ptau 2021-02-11T07:15:18-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-highlight-promising-alzheimers-vaccine-svb-leerink 2021-02-17T10:20:13-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-new-data-alpha-synuclein-and-tdp-43-programs 2021-02-24T07:11:55-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-presents-new-preclinical-data-therapeutic-and 2021-03-09T07:05:02-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-new-clinical-results-down-syndrome-and-plans 2021-03-16T07:08:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2020-financial-results-and-provides 2021-03-23T07:03:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-webinar-highlighting-its-innovative-morphomertm 2021-03-26T08:43:03-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-hosts-investor-webinar-highlighting-power-its 2021-03-31T08:10:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-appoints-experienced-biotech-and-investment-executive 2021-03-31T16:39:03-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-quarter-2021-financial-results-and 2021-04-28T08:38:05-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-expansion-phase-1b2a-phospho-tau-alzheimers 2021-05-17T13:28:45-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-highlight-first-class-alzheimers-disease-vaccine 2021-05-20T07:32:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provides-update-alzheimers-disease-vaccine-candidates 2021-06-02T07:11:30-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-holds-its-annual-general-meeting-shareholders 2021-06-25T09:25:40-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-strategic-acquisition-industry-leading 2021-07-27T08:45:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-presents-full-phase-1b-results-anti-abeta-vaccine-and 2021-07-29T07:33:53-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2021-financial-results-and 2021-08-04T07:30:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-first-positive-cognitive-results-tau 2021-08-31T07:32:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-participate-upcoming-virtual-investor-conferences 2021-09-02T07:03:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-ceo-andrea-pfeifer-receives-first-sefwomenaward-ceo 2021-09-03T08:12:57-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/scrip-askswhat-does-2021-hold-biopharma 2022-03-28T16:40:10-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/nih-catalyst-bringing-precision-medicine-neuroscience 2022-03-28T16:40:48-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/food-pharma-andrea-pfeifers-trek-cure-alzheimers 2022-03-28T16:41:25-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/covid-19-vaccine-offers-road-map-tackling-dementia-heres-how-0 2022-03-28T16:43:16-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/roadmap-successful-treatment-alzheimers-disease 2022-03-28T16:41:54-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/pharmavoice-2019-anthology-woman-week-wow 2022-03-28T16:42:23-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/hope-rekindled-alzheimers-disease-treatment 2022-03-28T16:42:48-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/how-ac-immune-ceo-andrea-pfeifer-plans-conquer-dementia 2022-03-28T16:43:52-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-london-healthcare-conference 2021-11-09T10:51:48-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-holds-its-extraordinary-general-meeting-and-appoints 2021-11-09T10:59:49-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/new-data-ac-immunes-abeta-and-ptau-clinical-programs-alzheimers 2021-11-09T11:23:36-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-extends-research-collaboration-university-pennsylvania 2021-11-09T11:24:58-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2021-financial-results-and 2021-11-09T11:28:26-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-late-breaker-presentation-genentech-ctad 2021-11-12T09:27:27-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-interim-phase-1b2a-data-showing-its-aci 2021-11-12T09:18:34-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-awarded-two-michael-j-fox-foundation-grants-advance 2022-03-16T15:21:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-svb-leerink-11th-annual-global-healthcare 2022-03-16T15:23:06-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-aci-24-data-brain-communications-show-abeta-vaccine 2022-03-16T15:25:04-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-aci-35030-phase-1b2a-trial-interim-data-confirm 2022-03-16T15:27:40-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/biotech-jahrbuch-transkriptde-alzheimer-neu-im-lichtkegel 2022-06-01T16:52:38-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-im-kampf-gegen-alzheimer-und-parkinson-eine 2022-03-28T16:37:40-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/hmw-inside-call-mit-dr-matthias-hallweger-und-prof-dr-andrea 2022-03-28T16:38:15-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/frankfurter-allgemeine-zeitung-die-frau-gegen-das-vergessen 2022-03-28T16:38:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/stopping-alzheimers-preventive-vaccine 2022-03-28T16:44:19-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/insight-report-potential-therapeutic-targets-alzheimers 2022-03-28T16:46:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/how-does-tdp-43-bog-brains-als-ftld-patients-ac-immune-enlists 2022-03-28T16:45:17-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/belief-early-interventions-will-be-key-treating-alzheimers 2022-03-28T16:46:09-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/self-protein-challenge 2022-03-28T16:47:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/vaccines-alzheimers-exploiting-similarities-down-syndrome 2022-03-28T16:45:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-gets-eu28m-eli-lilly-alzheimers-drug-hits-phase-i 2022-03-28T16:44:48-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-ceo-andrea-pfeifer-provides-overview-her-career-date 2022-03-28T16:53:19-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/early-results-alzheimers-vaccine-trial-people-down-syndrome 2022-03-28T16:51:29-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-ceo-andrea-pfeifer-speaks-heidinews-about-companys 2022-03-28T16:55:04-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/mark-worlds-alzheimer-day-andrea-pfeifer-shares-ac-immunes 2022-03-28T16:54:02-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/mark-world-alzheimers-month-ac-immunes-ceo-andrea-pfeifer-shared 2022-03-28T16:55:55-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ceo-andrea-pfeifer-prof-andrea-pfeifer-speaks-laura-elizabeth 2022-03-28T16:56:27-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ceo-andrea-pfeifer-talks-pharmavoice-us-pharmaceutical-trade 2022-03-28T16:57:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ceo-andrea-pfeifer-formed-basis-extensive-article-sp-global 2022-03-28T16:58:12-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ceo-andrea-pfeifer-has-been-recognized-one-top-20-women-leading 2022-03-28T16:57:45-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ceo-andrea-pfeifer-talks-about-ac-immunes-roadmap-successful 2022-03-28T16:58:50-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/webcast-ac-immune-ceo-andrea-pfeifer-hc-wainwright-london 2022-03-28T16:59:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-ceo-andrea-pfeifer-talks-about-synuclein-pet-project 2022-03-28T16:59:37-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/endpoint-news-names-ac-immune-deal-eli-lilly-top-10-alzheimers 2022-03-28T17:00:02-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/phase-2-trial-tau-antibody-ro7105705-recruiting-patients 2022-03-28T17:00:52-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/webcast-ac-immune-ceo-andrea-pfeifer-world-economic-forum 2022-03-28T17:01:18-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/we-will-find-cure-alzheimers 2022-03-28T17:01:56-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-nasdaq-opening-bell-ceremony-cnbc 2022-03-28T17:02:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/woman-whos-committed-curing-alzheimers-disease 2022-03-28T17:03:15-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/diversity-requires-openness 2022-03-28T17:03:39-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/it-takes-tau-tangle 2022-03-28T17:04:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-adpdtm-2022-new-clinical-and-preclinical-data 2022-03-16T15:29:01-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-live-images-alpha-synuclein-human-brain 2022-03-16T15:30:16-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-webinar-alpha-synuclein-target 2022-03-21T07:34:38-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2021-financial-results-and-provides 2022-03-23T09:36:29-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/prof-andrea-pfeifer-will-mit-ihrer-firma-eine-stille-pandemie 2022-03-28T17:33:47-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-kol-webinar-first-clinical-proof-concept-alpha 2022-03-30T08:07:07-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-clears-first-hurdle-synuclein-pet-tracer 2022-06-09T05:13:32-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-changes-senior-management 2022-04-14T12:25:27-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/focus-parkinson-fruher-erkennen 2022-04-12T13:23:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-b-riley-annual-neuro-ophthalmology-virtual 2022-04-27T08:04:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-quarter-2022-financial-results-and 2022-04-28T07:57:59-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-anti-abeta-vaccine-results-phase-1b-study-down 2022-05-09T16:03:33-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-ceo-andrea-pfeifer-receives-aenne-burda-award 2022-05-17T09:19:56-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-2022-jefferies-healthcare-conference 2022-06-06T15:53:21-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/focus-im-interview-mit-dr-kurt-martin-mayer 2022-06-01T13:47:28-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/innovator-news-ac-immunes-quest-make-alzheimers-disease 2022-06-03T12:52:06-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/il-nest-pas-possible-de-soigner-alzheimer 2022-06-07T11:09:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/bunte-wir-haben-bei-parkinson-endlich-einen-durchbruch-erzielt 2022-06-09T05:07:36-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provides-update-alzheimers-prevention-initiative-study 2022-06-16T01:01:27-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-holds-annual-general-meeting-shareholders 2022-06-24T16:35:46-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-upcoming-presentations-alzheimers 2022-07-22T12:02:23-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2022-financial-results-and 2022-07-28T07:34:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/detailed-data-phase-ii-crenezumab-alzheimers-prevention 2022-08-02T11:04:17-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-webinar-vaccinations-treat-and 2022-08-11T08:11:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-kol-webinar-potential-benefits-vaccines-alzheimers-and 2022-08-24T16:20:27-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-grant-michael-j-fox-foundation-continued 2022-09-01T08:41:43-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-partner-lmi-progresses-tau-pet-tracer-pi-2620-late 2022-09-26T07:41:31-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-opens-new-centers-phase-1b2-trial-evaluating-aci-24 2022-10-04T10:35:45-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/image-worth-decade-scientific-resolve 2022-10-25T05:32:54-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/kooperationen-fur-gelungene-medikamentenentwicklung 2022-10-26T12:52:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2022-financial-results-and 2022-10-28T08:16:48-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-london-healthcare-conference-0 2022-11-08T10:42:29-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-progress-alzheimers-disease-programs-targeting 2022-11-23T10:04:21-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-alzheimers-disease-vaccine-candidate-aci-35030 2022-11-30T07:00:37-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-partner-life-molecular-imaging-initiates-phase-3-study 2023-01-18T10:34:18-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-aci-24060-anti-amyloid-beta-vaccine-alzheimers-shows 2023-01-26T07:06:41-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-svb-securities-global-biopharma-conference 2023-02-02T08:21:11-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-awarded-new-grants-mjff-and-target-als-supporting 2023-03-16T07:18:08-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-report-full-year-2022-financial-results-and-provide 2023-11-07T08:42:01-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2022-financial-results-and-provides 2023-03-16T07:17:51-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-adpdtm-2023-present-new-clinical-and-preclinical-data 2023-03-20T08:54:44-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-key-opinion-leader-webinar-early-diagnosis-and 2023-04-05T10:03:36-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-quarter-2023-financial-results-and 2023-04-28T07:45:25-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/alzheimer-hoffnung 2023-05-10T06:19:00-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-holds-annual-general-meeting-shareholders-0 2023-11-07T08:40:08-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-fda-fast-track-designation-anti-amyloid-beta 2023-11-07T08:38:16-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-showcasing-precision-medicine-programs-aaic-2023 2023-11-07T08:36:08-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sa-appoints-new-chief-medical-officer 2023-11-07T08:20:27-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-btig-virtual-biotechnology-conference-2023 2023-11-07T08:18:40-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2023-financial-results-and 2023-08-04T09:13:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-hc-wainwright-25th-annual-global-investment 2023-11-07T08:17:04-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-2023-cns-neuro-summit-october-2023 2023-11-07T08:15:18-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-upcoming-presentations-16th-ctad-conference 2023-11-07T08:13:26-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-clinical-data-published-nature-communications-show 2023-11-07T08:11:43-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-host-kol-webinar-amyloid-plaque-pet-imaging-alzheimers 2023-11-07T08:08:40-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2023-financial-results-and 2023-11-07T07:34:07-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-2023-london-healthcare-conference 2023-11-07T07:22:17-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-strengthens-management-appoints-madiha-derouazi-cso 2023-12-01T08:06:54-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-targeted-anti-ptau-active-immunotherapy-alzheimers 2024-01-02T15:02:25-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-pricing-underwritten-offering-common-shares 2024-01-02T15:03:52-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-progress-update-phase-2-active-immunotherapy-clinical 2024-02-02T04:25:44-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-regain-global-rights-crenezumab-and-semorinemab 2024-01-22T09:19:42-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-upcoming-presentations-adpdtm-2024 2024-02-26T08:22:45-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2023-financial-results-and-provides 2024-03-14T09:39:14-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-and-takeda-sign-exclusive-option-and-license-agreement 2024-05-13T06:23:17-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-quarter-2024-financial-results-and 2024-05-13T06:09:25-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-global-healthcare-conference-june 2024-05-28T11:29:09-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-showcasing-its-novel-morphomer-antibody-drug-conjugate 2024-07-16T07:00:22-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-aci-35030-now-jnj-2056-granted-fda-fast-track 2024-07-25T07:15:42-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-unveils-novel-therapeutic-antibody-drug-conjugate-adc 2024-07-31T08:48:03-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2024-financial-results-and 2024-08-06T07:14:06-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immunes-pi-2620-tau-pet-diagnostic-phase-3-receives-fast 2024-08-28T09:28:49-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-second-milestone-payment-following-progress 2024-09-17T09:12:01-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2024-financial-results-and 2024-11-05T09:56:17-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-2024-london-healthcare-conference 2024-11-13T07:06:56-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-positive-interim-results-phase-2-trial-aci 2024-11-14T09:42:05-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-interim-safety-data-phase-1b2-abate-trial-aci 2024-12-10T07:53:33-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-participate-upcoming-investor-conferences 2025-03-04T07:53:59-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2024-financial-results-and-provides 2025-03-13T08:10:39-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-upcoming-presentations-and-industry 2025-03-25T08:49:05-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-further-positive-interim-results-phase-2-trial 2025-04-02T09:21:53-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-first-quarter-2025-financial-results-and 2025-04-30T07:10:35-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-second-quarter-2025-financial-results-and 2025-08-05T07:16:13-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-sharpens-pipeline-focus-operational-efficiencies 2025-09-04T07:07:34-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/peer-reviewed-results-phase-1b2a-trial-anti-ptau-active 2025-09-25T09:16:00-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/first-characterization-tdp-43-pet-tracer-published-nature 2025-10-24T09:21:10-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-appoints-renowned-neurologist-catherine-mummery-chair 2025-10-28T09:54:48-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-third-quarter-2025-financial-results-and 2025-11-04T07:51:02-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-present-jefferies-2025-london-healthcare-conference 2025-11-11T07:25:37-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-positive-interim-phase-2-data-aci-7104056-support 2025-12-11T07:01:06-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-initiates-phase-1-clinical-trial-nlrp3-inhibitor 2026-02-24T07:10:47-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-upcoming-industry-symposium-parkinsons 2026-03-05T09:11:33-05:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-full-year-2025-financial-results-and-provides 2026-03-13T12:38:28-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-presents-first-vivo-images-brain-tdp-43-pathology 2026-03-19T09:52:00-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-amendment-morphomer-r-tau-license-and-0 2026-04-07T09:41:27-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-initiates-final-cohort-ongoing-phase-1b2-abate-trial 2026-04-30T07:01:04-04:00 0.5 https://ir.acimmune.com/news-releases/news-release-details/ac-immune-first-quarter-2026-financial-and-corporate-updates 2026-04-30T07:50:14-04:00 0.5 https://ir.acimmune.com/sec-filings/sec-filing/f-1/0001193125-16-607922 2016-05-31T13:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-622656 2016-06-15T17:32:14-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-645087 2016-07-11T11:42:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-702253 2016-09-07T06:06:10-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-708561 2016-09-13T16:43:10-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-711781 2016-09-16T11:28:47-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/fwp/0001193125-16-711830 2016-09-16T12:04:47-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-715981 2016-09-21T16:34:47-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/fwp/0001193125-16-716050 2016-09-21T17:07:43-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-1a/0001193125-16-716813 2016-09-22T12:58:10-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/effect/9999999995-16-005750 2021-07-09T20:00:00-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/8-a12b/0001193125-16-717617 2016-09-23T07:03:33-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/ct-order/9999999997-16-025958 2021-07-09T20:00:00-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/certnas/9999999997-16-025984 2021-07-09T20:00:00-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b4/0001193125-16-718500 2016-09-23T16:46:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/s-8/0000950103-16-016688 2016-09-29T16:26:15-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-16-017052 2016-10-13T16:14:09-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-16-017842 2016-11-14T06:12:08-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-16-017884 2016-11-15T07:28:49-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001193125-16-775947 2016-11-23T10:01:54-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-16-018724 2016-12-16T06:05:40-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0000950103-17-001350 2017-02-13T16:09:11-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0000950103-17-001352 2017-02-13T16:18:06-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0000315066-17-001405 2017-02-14T10:51:30-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0001193125-17-043364 2017-02-14T16:21:31-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0001193125-17-043385 2017-02-14T16:22:40-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/s-8/0000950103-17-002312 2017-03-08T16:36:48-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-002539 2017-03-17T06:32:10-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0000950103-17-002540 2017-03-17T06:34:10-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-004487 2017-05-11T06:11:27-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-005304 2017-06-01T16:47:12-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-006153 2017-06-28T07:25:36-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-007724 2017-08-09T06:13:08-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-010692 2017-11-02T06:59:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-17-011057 2017-11-13T06:34:01-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000315066-18-000991 2018-02-13T09:40:25-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000950103-18-001962 2018-02-13T16:52:38-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000950103-18-001963 2018-02-13T16:52:38-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-003507 2018-03-20T06:10:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0000950103-18-003508 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-003631 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-003728 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-005330 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-005703 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3/0000950103-18-005925 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3a/0000950103-18-006520 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-007213 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/effect/9999999995-18-001454 2021-07-09T20:00:00-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-008399 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-008562 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-18-008583 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-18-008673 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-18-008705 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-008738 2023-03-20T10:46:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-009167 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-009503 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3/0000950103-18-009949 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/effect/9999999995-18-002309 2021-07-09T20:00:00-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-012266 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-012517 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-013293 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-014474 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-18-014591 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-000152 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-000780 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-001043 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001213900-19-001625 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-001815 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0000921895-19-000300 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000950103-19-001918 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000315066-19-000848 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-002104 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-003577 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0000950103-19-003578 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-19-000857 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-fa/0000950103-19-004949 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-006414 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-007563 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-008738 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-009291 2023-03-20T10:46:34-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-009388 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-010115 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/s-8/0000950103-19-010479 2021-07-09T20:00:00-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-010822 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-19-002420 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-012523 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-015197 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-19-015378 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001213900-20-002768 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000315066-20-000787 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-20-000537 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-005734 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-20-000800 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-20-000092 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-20-001675 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0000950103-20-006219 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-006220 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-006760 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-008879 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-010022 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-012491 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-013671 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-015298 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-20-017578 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-017581 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-018537 2023-03-20T10:46:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-020362 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3/0000950103-20-020540 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/effect/9999999995-20-003091 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-022116 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-022435 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-20-022675 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-ka/0000950103-20-022732 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-20-010280 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-20-021406 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-21-000086 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0000935836-21-000056 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-002132 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001213900-21-008736 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0000059478-21-000078 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-003100 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0000950103-21-004378 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-004379 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-004994 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-006207 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3/0000950103-21-006233 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-21-006776 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-006778 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/effect/9999999995-21-001806 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-007582 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-21-005539 2023-03-20T10:47:02-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-21-006590 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-009379 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-011194 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-011884 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13g/0001214659-21-008188 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-19-016116 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-19-017444 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-013248 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-714836 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-645097 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-18-015338 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-622660 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-708570 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-18-006521 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/drsa/0001564590-15-008267 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-18-010504 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-714833 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/drsa/0000950123-15-010452 2023-03-20T10:47:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-16-077994 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-15-047108 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/drsa/0000950123-16-016105 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/drs/0000950123-15-009640 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-16-092220 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-18-007185 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-15-056355 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/drsa/0000950123-15-012389 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-15-050235 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-16-080781 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-616794 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-16-080419 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-16-092993 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-715027 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-607939 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-18-026898 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0001193125-16-711787 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/drsa/0000950123-15-009912 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-015589 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-015922 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-016940 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-017470 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-21-017734 2023-03-20T10:47:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000935836-22-000139 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-22-000532 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-004656 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001140361-22-010440 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0001140361-22-010439 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-006172 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-007208 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-22-008805 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-009249 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-010712 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-011230 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-013084 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-013479 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-016378 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001104659-22-112189 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-22-020429 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-001048 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000059478-23-000018 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001213900-23-010279 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-23-000467 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001214659-23-002479 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-003956 2023-03-20T10:47:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0001558370-23-003963 2023-03-20T12:02:50-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001104659-23-033059 2023-03-20T12:09:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-23-007153 2023-04-28T07:31:57-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-007743 2023-05-24T16:19:20-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-009218 2023-06-26T08:48:42-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-009306 2023-06-27T08:25:54-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-001996 2023-06-30T16:20:06-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002010 2023-06-30T17:03:13-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002040 2023-07-03T13:24:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002179 2023-07-07T16:16:22-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002211 2023-07-10T16:18:37-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002274 2023-07-12T16:08:35-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002308 2023-07-13T16:29:27-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002399 2023-07-18T16:12:25-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002481 2023-07-21T16:08:52-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002505 2023-07-24T16:23:57-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-010770 2023-07-26T07:19:32-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-23-013301 2023-08-04T07:35:41-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002849 2023-08-08T16:21:51-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-002898 2023-08-09T16:17:29-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-003226 2023-08-17T16:17:14-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-003307 2023-08-21T16:26:24-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-003367 2023-08-22T16:19:16-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-23-017498 2023-11-03T07:31:54-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-016936 2023-12-01T07:16:33-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-005739 2023-12-06T16:38:52-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-005849 2023-12-11T16:19:31-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-017504 2023-12-15T07:29:09-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-006147 2023-12-15T16:34:18-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-23-017553 2023-12-15T17:29:26-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-23-017643 2023-12-19T08:56:27-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-23-002779 2023-12-19T16:54:56-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-23-006522 2023-12-28T16:24:12-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-000177 2024-01-03T16:23:35-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-000942 2024-01-22T07:55:51-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001214659-24-002252 2024-02-09T16:32:32-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0001558370-24-003164 2024-03-14T07:38:46-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001104659-24-034238 2024-03-14T07:47:14-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3/0000950103-24-003853 2024-03-14T16:47:41-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-006573 2024-05-13T06:10:30-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-24-007857 2024-05-13T06:22:26-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001965301-24-000070 2024-05-16T14:25:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-006931 2024-05-21T08:05:15-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-008566 2024-06-20T16:38:17-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-010718 2024-07-25T08:03:08-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/f-3a/0000950103-24-010895 2024-07-26T16:55:26-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-011251 2024-07-31T08:36:51-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/effect/9999999995-24-002330 2024-08-01T06:10:29-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-24-010944 2024-08-06T07:23:50-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-011753 2024-08-06T16:09:47-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/424b5/0000950103-24-011782 2024-08-06T16:51:37-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-012695 2024-08-28T09:05:18-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/corresp/0000950103-24-010979 2024-08-29T00:07:50-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/upload/0000000000-24-002947 2024-08-29T00:08:12-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-013644 2024-09-17T07:08:05-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-24-007232 2024-09-18T16:43:40-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-013746 2024-09-19T16:32:32-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-24-007431 2024-09-27T16:28:11-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-24-014326 2024-11-05T07:21:30-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-016272 2024-11-14T07:04:51-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0000921895-24-002730 2024-11-14T16:38:37-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-017481 2024-12-10T08:25:30-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/sc-13ga/0001214659-24-020510 2024-12-13T17:17:03-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-24-017948 2024-12-18T17:18:01-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0001558370-25-002855 2025-03-13T07:33:40-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001104659-25-023225 2025-03-13T07:37:09-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-25-005922 2025-04-30T07:16:24-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-25-006151 2025-05-19T06:33:53-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-25-007254 2025-06-11T16:10:55-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-25-007642 2025-06-20T06:05:32-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-25-005188 2025-07-24T16:26:24-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001558370-25-010174 2025-08-05T07:03:04-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-25-011258 2025-09-04T07:02:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-25-007069 2025-09-12T16:45:41-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-25-007735 2025-10-03T16:29:45-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001104659-25-105896 2025-11-04T07:03:24-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-25-015983 2025-12-11T07:07:40-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-26-000470 2026-01-15T16:26:06-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-26-002195 2026-02-17T16:37:08-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-26-002519 2026-02-24T07:33:38-05:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/20-f/0001104659-26-027342 2026-03-13T07:04:38-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0001104659-26-027345 2026-03-13T07:05:36-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004151 2026-03-18T12:21:25-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004150 2026-03-18T12:21:44-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004153 2026-03-18T12:33:28-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004155 2026-03-18T12:36:31-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004156 2026-03-18T12:37:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004163 2026-03-18T13:12:31-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-004453 2026-03-20T12:02:51-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/3/0000950103-26-005191 2026-04-01T16:54:44-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-26-005409 2026-04-07T07:36:49-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/144/0001950047-26-003516 2026-04-15T16:52:56-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/4/0001651625-26-000005 2026-04-16T11:15:41-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/4a/0001651625-26-000006 2026-04-16T12:41:59-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-26-006498 2026-04-30T07:05:42-04:00 0.4 https://ir.acimmune.com/sec-filings/sec-filing/6-k/0000950103-26-006499 2026-04-30T07:09:58-04:00 0.4 https://ir.acimmune.com/letter-investors 2020-05-12T08:44:18-04:00 0.4 https://ir.acimmune.com/privacy-notice-agm 2025-05-19T05:51:00-04:00 0.4 https://ir.acimmune.com/privacy-notice-egm 2021-11-09T11:50:19-05:00 0.4 https://ir.acimmune.com/analyst/peter-welford 2024-06-02T06:46:56-04:00 0.5 https://ir.acimmune.com/analyst/paul-matteis 2024-06-02T06:47:21-04:00 0.5 https://ir.acimmune.com/analyst/fein 2024-06-02T06:46:29-04:00 0.5 https://ir.acimmune.com/monika-butler 2025-01-31T09:09:37-05:00 0.5 https://ir.acimmune.com/board-member/roy-twyman 2022-03-16T11:31:53-04:00 0.5 https://ir.acimmune.com/analyst/thomas-shrader 2024-06-02T06:45:54-04:00 0.5 https://ir.acimmune.com/board-member/martin-zugel 2025-06-19T12:24:46-04:00 0.5 https://ir.acimmune.com/board-member/renee-aguiar-lucander 2025-06-19T12:23:58-04:00 0.5